SEAGEN INC

Organization

BOTHELL, WA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
CD47 antibodies and uses thereof for treating cancer
- Patent number 12,071,480
- Issue date Aug 27, 2024
- SEAGEN INC.
- Shyra Gardai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of HER2 positive cancers
- Patent number 12,048,698
- Issue date Jul 30, 2024
- SEAGEN INC.
- Scott Peterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective drug release from internalized conjugates of biologically...
- Patent number 12,036,286
- Issue date Jul 16, 2024
- SEAGEN INC.
- Noah Bindman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Drug conjugates with self-stabilizing linkers having improved physi...
- Patent number 11,944,689
- Issue date Apr 2, 2024
- SEAGEN INC.
- Philip Moquist
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cysteine mutated antibodies for conjugation
- Patent number 11,938,194
- Issue date Mar 26, 2024
- SEAGEN INC.
- Andrew Waight
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quaternized nicotinamide adenine dinucleotide salvage pathway inhib...
- Patent number 11,931,414
- Issue date Mar 19, 2024
- SEAGEN INC.
- Christopher Scott Neumann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
T cells with reduced surface fucosylation and methods of making and...
- Patent number 11,891,644
- Issue date Feb 6, 2024
- SEAGEN INC.
- Nicole Okeley
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Hydrophobic Auristatin F compounds and conjugates thereof
- Patent number 11,857,565
- Issue date Jan 2, 2024
- SEAGEN INC.
- Svetlana O. Doronina
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for the preparation of pegylated drug-linkers and intermedi...
- Patent number 11,844,839
- Issue date Dec 19, 2023
- SEAGEN INC.
- Yunyu Mao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-AVB6 antibodies and antibody-drug conjugates
- Patent number 11,827,709
- Issue date Nov 28, 2023
- SEAGEN INC.
- Maureen Ryan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glypican 3 antibodies and conjugates thereof
- Patent number 11,819,553
- Issue date Nov 21, 2023
- SEAGEN INC.
- Travis Biechele
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating myelodysplastic syndrome and acute myeloid leuk...
- Patent number 11,820,827
- Issue date Nov 21, 2023
- SEAGEN INC.
- Shyra Gardai
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Conjugates of quaternized tubulysin compounds
- Patent number 11,793,880
- Issue date Oct 24, 2023
- SEAGEN INC.
- Patrick J. Burke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
BCMA antibodies and use of same to treat cancer and immunological d...
- Patent number 11,767,365
- Issue date Sep 26, 2023
- SEAGEN INC.
- Django Sussman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of glucuronide drug-linkers and interme...
- Patent number 11,730,822
- Issue date Aug 22, 2023
- SEAGEN INC.
- Yunyu Mao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of HER2 positive cancers
- Patent number 11,666,572
- Issue date Jun 6, 2023
- SEAGEN INC.
- Scott Peterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective reduction of proteins
- Patent number 11,667,696
- Issue date Jun 6, 2023
- SEAGEN INC.
- Damon L. Meyer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted delivery of nicotinamide adenine dinucleotide salvage path...
- Patent number 11,638,762
- Issue date May 2, 2023
- SEAGEN INC.
- Christopher Scott Neumann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates (ADC) that bind to 158P1D7 proteins
- Patent number 11,634,503
- Issue date Apr 25, 2023
- AGENSYS, INC.
- Robert Kendall Morrison
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD228 antibodies and antibody-drug conjugates
- Patent number 11,617,798
- Issue date Apr 4, 2023
- SEAGEN INC.
- Sharsti Sandall
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for the preparation of drug linker compounds
- Patent number 11,612,666
- Issue date Mar 28, 2023
- SEAGEN INC.
- Sophie Blanchard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synergistic effects between auristatin-based antibody drug conjugat...
- Patent number 11,607,460
- Issue date Mar 21, 2023
- SEAGEN INC.
- Timothy S. Lewis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycan-interacting compounds and methods of use
- Patent number RE49435
- Issue date Feb 28, 2023
- SEAGEN INC.
- Julie DeSander
Information Patent Grant
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
- Patent number 11,559,582
- Issue date Jan 24, 2023
- AGENSYS, INC.
- Daulet Satpayev
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conj...
- Patent number 11,559,558
- Issue date Jan 24, 2023
- SEAGEN INC.
- Eric Sievers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multi-drug antibody drug conjugates
- Patent number 11,541,128
- Issue date Jan 3, 2023
- SEAGEN INC.
- Matthew R. Levengood
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydrophilic antibody-drug conjugates
- Patent number 11,510,959
- Issue date Nov 29, 2022
- SEAGEN INC.
- Svetlana Doronina
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Glycan-interacting compounds and methods of use
- Patent number 11,401,330
- Issue date Aug 2, 2022
- SEAGEN INC.
- David A. Eavarone
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-TIGIT antibodies
- Patent number 11,401,339
- Issue date Aug 2, 2022
- SEAGEN INC.
- Julia C. Piasecki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the preparation of tubulysins and intermediates thereof
- Patent number 11,389,543
- Issue date Jul 19, 2022
- SEAGEN INC.
- Kun-Liang Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
Antibody Masking Domains
- Publication number 20240352080
- Publication date Oct 24, 2024
- Seagen Inc.
- Vivian Trang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING MULTIPLE MYELOMA
- Publication number 20240343819
- Publication date Oct 17, 2024
- Seagen Inc.
- Phoenix Ho
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods for Targeting Cancer Stem Cells
- Publication number 20240343826
- Publication date Oct 17, 2024
- Seagen Inc.
- David A. Eavarone
- G01 - MEASURING TESTING
Information Patent Application
Glycan-Interacting Compounds and Methods of Use
- Publication number 20240342279
- Publication date Oct 17, 2024
- Seagen Inc.
- Ana Paula Galvao da Silva
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and Methods for Targeting Cancer Stem Cells
- Publication number 20240343834
- Publication date Oct 17, 2024
- Seagen Inc.
- David A. Eavarone
- G01 - MEASURING TESTING
Information Patent Application
PEGYLATED DRUG-LINKERS FOR IMPROVED LIGAND-DRUG CONJUGATE PHARMACOK...
- Publication number 20240325561
- Publication date Oct 3, 2024
- Seagen Inc.
- Robert LYON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUATERNIZED NICOTINAMIDE ADENINE DINUCLEOTIDE SALVAGE PATHWAY INHIB...
- Publication number 20240293554
- Publication date Sep 5, 2024
- Seagen Inc.
- Christopher Scott NEUMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CAMPTOTHECIN PEPTIDE CONJUGATES
- Publication number 20240277860
- Publication date Aug 22, 2024
- Seagen Inc.
- Scott C. JEFFREY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTHRACYCLINE ANTIBODY CONJUGATES
- Publication number 20240261422
- Publication date Aug 8, 2024
- Seagen Inc.
- Patrick J. Burke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BETA-GLUCURONIDE-LINKER DRUG CONJUGATES
- Publication number 20240252672
- Publication date Aug 1, 2024
- Seagen Inc.
- Scott JEFFREY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES
- Publication number 20240247030
- Publication date Jul 25, 2024
- Seagen Inc.
- Patrick J. BURKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER
- Publication number 20240247059
- Publication date Jul 25, 2024
- Seagen Inc.
- Maria Leia SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF REDUCING SIDE EFFECTS OF ANTI-CD30 ANTIBODY DRUG CONJUGA...
- Publication number 20240245753
- Publication date Jul 25, 2024
- Seagen Inc.
- Thomas Manley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DRUG CONJUGATES WITH SELF-STABILIZING LINKERS HAVING IMPROVED PHYSI...
- Publication number 20240226320
- Publication date Jul 11, 2024
- Seagen Inc.
- Philip MOQUIST
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CEACAM5 ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF
- Publication number 20240226313
- Publication date Jul 11, 2024
- SANOFI
- Yves BAUDAT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HYDROPHOBIC AURISTATIN F COMPOUNDS AND CONJUGATES THEREOF
- Publication number 20240216420
- Publication date Jul 4, 2024
- Seagen Inc.
- Svetlana O. DORONINA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR THE PREPARATION OF GLUCURONIDE DRUG-LINKERS AND INTERME...
- Publication number 20240207435
- Publication date Jun 27, 2024
- Seagen Inc.
- Yunyu MAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE DRUG RELEASE FROM INTERNALIZED CONJUGATES OF BIOLOGICALLY...
- Publication number 20240207427
- Publication date Jun 27, 2024
- Seagen Inc.
- Scott JEFFREY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR THE PREPARATION OF PEGYLATED DRUG-LINKERS AND INTERMEDI...
- Publication number 20240197889
- Publication date Jun 20, 2024
- Seagen Inc.
- Yunyu MAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CD70 Binding Agents and Uses Thereof
- Publication number 20240190981
- Publication date Jun 13, 2024
- Seagen Inc.
- Charlotte McDonagh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY
- Publication number 20240173421
- Publication date May 30, 2024
- Seagen Inc.
- Philip MOQUIST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLYPICAN 3 ANTIBODIES AND CONJUGATES THEREOF
- Publication number 20240173427
- Publication date May 30, 2024
- Seagen Inc.
- Travis Biechele
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOSTIMULATORY COMPOUNDS AND CONJUGATES
- Publication number 20240165251
- Publication date May 23, 2024
- Seagen Inc.
- Kung-Pern WANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING CANCER WITH NONFUCOSYLATED ANTI-CD70 ANTIBODIES
- Publication number 20240166757
- Publication date May 23, 2024
- Seagen Inc.
- Shyra GARDAI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING CANCER WITH A COMBINATION OF A NONFUCOSYLATED A...
- Publication number 20240165229
- Publication date May 23, 2024
- Seagen Inc.
- Daniel Diolaiti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONJUGATES OF QUATERNIZED TUBULYSIN COMPOUNDS
- Publication number 20240156969
- Publication date May 16, 2024
- Seagen Inc.
- Patrick J. BURKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER
- Publication number 20240158484
- Publication date May 16, 2024
- Seagen Inc.
- Matt ONSUM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF QUANTIFYING ANTI-CD40 ANTIBODIES
- Publication number 20240142463
- Publication date May 2, 2024
- Seagen Inc.
- Shawna Hengel
- G01 - MEASURING TESTING
Information Patent Application
WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJ...
- Publication number 20240139275
- Publication date May 2, 2024
- Seagen Inc.
- Eric Sievers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNERGISTIC EFFECTS BETWEEN AURISTATIN-BASED ANTIBODY DRUG CONJUGAT...
- Publication number 20240131176
- Publication date Apr 25, 2024
- Seagen Inc.
- Timothy S. Lewis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
98473092 - VODISVA
- Serial number 98473092
- Filing date Mar 28, 2024
- Seagen Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98088562 - SEATTLEGENETICS
- Serial number 98088562
- Filing date Jul 17, 2023
- Seagen Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97766377 - SGN
- Serial number 97766377
- Registration number 7351199
- Filing date Jan 24, 2023
- Seagen Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97766451 - SGN
- Serial number 97766451
- Filing date Jan 24, 2023
- Seagen Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97766623 - SGEN
- Serial number 97766623
- Filing date Jan 24, 2023
- Seagen Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97387050 - TIVDAK
- Serial number 97387050
- Registration number 7179457
- Filing date Apr 28, 2022
- Seagen Inc.
- 44 - Medical services
Information Trademark
97387047
- Serial number 97387047
- Registration number 7179456
- Filing date Apr 28, 2022
- Seagen Inc.
- 44 - Medical services
Information Trademark
97326585 - LET'S TALK BLADDER CANCER
- Serial number 97326585
- Registration number 7077094
- Filing date Mar 23, 2022
- Agensys, Inc.
- 44 - Medical services
Information Trademark
97313710 - ADCETRIS
- Serial number 97313710
- Registration number 6949905
- Filing date Mar 15, 2022
- Seagen Inc.
- 44 - Medical services
Information Trademark
97171782 - CEME
- Serial number 97171782
- Registration number 7007963
- Filing date Dec 14, 2021
- Seagen Inc.
- 35 - Advertising
Information Trademark
90675409 - TIVDAQ
- Serial number 90675409
- Filing date Apr 27, 2021
- Seagen Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90675414 - TIVDAKT
- Serial number 90675414
- Filing date Apr 27, 2021
- Seagen Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90142726 - SEAGEN
- Serial number 90142726
- Registration number 6680450
- Filing date Aug 27, 2020
- SEAGEN INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
90083550
- Serial number 90083550
- Registration number 6680407
- Filing date Jul 30, 2020
- SEAGEN INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88983160
- Serial number 88983160
- Registration number 6584407
- Filing date May 5, 2020
- Seattle Genetics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88983161 - TIVDAK
- Serial number 88983161
- Registration number 6598715
- Filing date Sep 25, 2018
- Seattle Genetics, Inc.
- 5 - Pharmaceutical and veterinary preparations

Organization

Patents Grantslast 30 patents

CD47 antibodies and uses thereof for treating cancer

Treatment of HER2 positive cancers

Selective drug release from internalized conjugates of biologically...

Drug conjugates with self-stabilizing linkers having improved physi...

Cysteine mutated antibodies for conjugation

Quaternized nicotinamide adenine dinucleotide salvage pathway inhib...

T cells with reduced surface fucosylation and methods of making and...

Hydrophobic Auristatin F compounds and conjugates thereof

Process for the preparation of pegylated drug-linkers and intermedi...

Anti-AVB6 antibodies and antibody-drug conjugates

Glypican 3 antibodies and conjugates thereof

Methods of treating myelodysplastic syndrome and acute myeloid leuk...

Conjugates of quaternized tubulysin compounds

BCMA antibodies and use of same to treat cancer and immunological d...

Process for the preparation of glucuronide drug-linkers and interme...

Treatment of HER2 positive cancers

Selective reduction of proteins

Targeted delivery of nicotinamide adenine dinucleotide salvage path...

Antibody drug conjugates (ADC) that bind to 158P1D7 proteins

Anti-CD228 antibodies and antibody-drug conjugates

Process for the preparation of drug linker compounds

Synergistic effects between auristatin-based antibody drug conjugat...

Glycan-interacting compounds and methods of use

Antibody drug conjugates (ADC) that bind to 191P4D12 proteins

Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conj...

Multi-drug antibody drug conjugates

Hydrophilic antibody-drug conjugates

Glycan-interacting compounds and methods of use

Anti-TIGIT antibodies

Process for the preparation of tubulysins and intermediates thereof

Patents Applicationslast 30 patents

Antibody Masking Domains

METHODS OF TREATING MULTIPLE MYELOMA

Compositions and Methods for Targeting Cancer Stem Cells

Glycan-Interacting Compounds and Methods of Use

Compositions and Methods for Targeting Cancer Stem Cells

PEGYLATED DRUG-LINKERS FOR IMPROVED LIGAND-DRUG CONJUGATE PHARMACOK...

QUATERNIZED NICOTINAMIDE ADENINE DINUCLEOTIDE SALVAGE PATHWAY INHIB...

CAMPTOTHECIN PEPTIDE CONJUGATES

ANTHRACYCLINE ANTIBODY CONJUGATES

BETA-GLUCURONIDE-LINKER DRUG CONJUGATES

TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES

HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER

METHODS OF REDUCING SIDE EFFECTS OF ANTI-CD30 ANTIBODY DRUG CONJUGA...

DRUG CONJUGATES WITH SELF-STABILIZING LINKERS HAVING IMPROVED PHYSI...

CEACAM5 ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF

HYDROPHOBIC AURISTATIN F COMPOUNDS AND CONJUGATES THEREOF

PROCESS FOR THE PREPARATION OF GLUCURONIDE DRUG-LINKERS AND INTERME...

SELECTIVE DRUG RELEASE FROM INTERNALIZED CONJUGATES OF BIOLOGICALLY...

PROCESS FOR THE PREPARATION OF PEGYLATED DRUG-LINKERS AND INTERMEDI...

Humanized Anti-CD70 Binding Agents and Uses Thereof

MODULATION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY

GLYPICAN 3 ANTIBODIES AND CONJUGATES THEREOF

IMMUNOSTIMULATORY COMPOUNDS AND CONJUGATES

METHODS OF TREATING CANCER WITH NONFUCOSYLATED ANTI-CD70 ANTIBODIES

METHODS OF TREATING CANCER WITH A COMBINATION OF A NONFUCOSYLATED A...

CONJUGATES OF QUATERNIZED TUBULYSIN COMPOUNDS

HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER

METHODS OF QUANTIFYING ANTI-CD40 ANTIBODIES

WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJ...

SYNERGISTIC EFFECTS BETWEEN AURISTATIN-BASED ANTIBODY DRUG CONJUGAT...

Trademarklast 30 trademarks

98473092 - VODISVA

98088562 - SEATTLEGENETICS

97766377 - SGN

97766451 - SGN

97766623 - SGEN

97387050 - TIVDAK

97387047

97326585 - LET'S TALK BLADDER CANCER

97313710 - ADCETRIS

97171782 - CEME

90675409 - TIVDAQ

90675414 - TIVDAKT

90142726 - SEAGEN

90083550

88983160